Detailed analysis of the histology-specific impact of ascites volume on the outcome of epithelial ovarian cancer: a multi-institutional retrospective cohort study

被引:0
作者
Iyoshi, Shohei [1 ,2 ]
Kimura, Mariko [3 ]
Yoshihara, Masato [1 ]
Kunishima, Atsushi [1 ]
Miyamoto, Emiri [1 ]
Fujimoto, Hiroki [1 ,4 ]
Kitami, Kazuhisa [1 ,5 ]
Mogi, Kazumasa [1 ]
Uno, Kaname [1 ]
Tano, Sho [1 ]
Yoshikawa, Nobuhisa [1 ]
Emoto, Ryo [6 ]
Matsui, Shigeyuki [6 ]
Kajiyama, Hiroaki [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, 65 Tsurumai Cho,Showa Ku, Nagoya 4668550, Japan
[2] Nagoya Univ, Inst Adv Res, Furo Cho,Chikusa Ku, Nagoya 4648601, Japan
[3] Okazaki City Hosp, Dept Obstet & Gynecol, 3-1 Goshoai,Kouryuji Cho, Okazaki 4448553, Japan
[4] Univ Adelaide, Robinson Res Inst, Adelaide Med Sch, Discipline Obstet & Gynaecol, Adelaide, SA, Australia
[5] Aichi Canc Ctr, Dept Gynecol Oncol, 1-1 Kanokoden,Chikusa Ku, Nagoya 4648681, Japan
[6] Nagoya Univ, Grad Sch Med, Dept Biostat, Nagoya, Japan
基金
日本学术振兴会;
关键词
Ovarian cancer; Ascites volume; Multi-institutional study; FALLOPIAN-TUBE; SURVIVAL; MODEL;
D O I
10.1186/s12885-024-13218-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe accumulation of ascites is a major symptom of ovarian cancer. The volume of ascites is a pathophysiological indicator of the peritoneal environment, such as inflammation and fibrosis; however, the relationship between the volume of ascites and oncological outcomes remains unclear. We herein retrospectively examined the effects of the volume of ascites on the prognosis of epithelial ovarian cancer in a multi-institutional large cohort using the stratification of clinical characteristics and statistical adjustment methods.MethodsOf 5,268 patients with ovarian tumors in the Tokai Ovarian Tumor Study Group between 1986 and 2020, we included 1,966 cases of epithelial ovarian cancer and examined the relationship between the volume of ascites at the initial surgery and the prognosis of patients. We performed a multivariate analysis and propensity score weighting for covariate adjustments to precisely estimate the prognostic impact of ascites accumulation. A subgroup analysis was also performed to examine differences in the prognostic implications of ascites accumulation among histotypes.ResultsA reservoir of 100 mL of ascites was confirmed as the cut-off value in our cohort. A Kaplan-Meyer analysis with propensity score adjustments indicated that the accumulation of more than 100 mL of ascites shortened overall survival. The multivariate analysis revealed that the increased accumulation of 100 mL of ascites was an independent prognostic factor for overall survival (HR 1.242; 95% CI 1.050-1.470; P = 0.012). The subgroup analysis showed the prognostic significance of ascites accumulation in mucinous and endometrioid histologies.ConclusionsThe accumulation of even a low to intermediate volume of ascites (>= 100 mL) was confirmed to be an independent poor prognostic factor in epithelial ovarian cancer. Furthermore, its prognostic impact differed among histotypes.
引用
收藏
页数:8
相关论文
共 29 条
[1]  
Aziz MAAE, 2019, Cancers, V11
[2]   Pathology and classification of ovarian tumors [J].
Chen, VW ;
Ruiz, B ;
Killeen, JL ;
Coté, TR ;
Wu, XC ;
Correa, CN .
CANCER, 2003, 97 (10) :2631-+
[3]   Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer [J].
Coosemans, An ;
Baert, Thais ;
D'Heygere, Victoria ;
Wouters, Roxanne ;
De laet, Lara ;
Van Hoylandt, Anais ;
Thirion, Gitte ;
Ceusters, Jolien ;
Laenen, Annouschka ;
Vandecaveye, Vincent ;
Vergote, Ignace .
ANTICANCER RESEARCH, 2019, 39 (11) :5953-5962
[4]   Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival [J].
Dabi, Yohann ;
Huchon, Cyrille ;
Ouldamer, Lobna ;
Bendifallah, Sofiane ;
Collinet, Pierre ;
Bricou, Alexandre ;
Darai, Emile ;
Ballester, Marcos ;
Lavoue, Vincent ;
Haddad, Bassam ;
Touboul, Cyril .
JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
[5]   Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites [J].
Feigenberg, Tomer ;
Clarke, Blaise ;
Virtanen, Carl ;
Plotkin, Anna ;
Letarte, Michelle ;
Rosen, Barry ;
Bernardini, Marcus Q. ;
Kollara, Alexandra ;
Brown, Theodore J. ;
Murphy, K. Joan .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[6]   The untapped potential of ascites in ovarian cancer research and treatment [J].
Ford, Caroline Elizabeth ;
Werner, Bonnita ;
Hacker, Neville Frederick ;
Warton, Kristina .
BRITISH JOURNAL OF CANCER, 2020, 123 (01) :9-16
[7]   Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer [J].
Iyoshi, Shohei ;
Yoshihara, Masato ;
Nakamura, Kae ;
Sugiyama, Mai ;
Koya, Yoshihiro ;
Kitami, Kazuhisa ;
Uno, Kaname ;
Mogi, Kazumasa ;
Tano, Sho ;
Tomita, Hiroyuki ;
Kajiwara, Keiji ;
Taki, Masayasu ;
Yamaguchi, Shigehiro ;
Nawa, Akihiro ;
Kajiyama, Hiroaki .
INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (11) :1961-1972
[8]   Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer [J].
Janco, Jo Marie Iran ;
Glaser, Gretchen ;
Kim, Bohyun ;
McGree, Michaela E. ;
Weaver, Amy L. ;
Cliby, William A. ;
Dowdy, Sean C. ;
Bakkum-Gamez, Jamie N. .
GYNECOLOGIC ONCOLOGY, 2015, 138 (01) :70-77
[9]   Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer [J].
Komiyama, Shinichi ;
Katabuchi, Hidetaka ;
Mikami, Mikio ;
Nagase, Satoru ;
Okamoto, Aikou ;
Ito, Kiyoshi ;
Morishige, Kenichiro ;
Suzuki, Nao ;
Kaneuchi, Masanori ;
Yaegashi, Nobuo ;
Udagawa, Yasuhiro ;
Yoshikawa, Hiroyuki .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) :435-446
[10]   Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer [J].
Lai, Ingrid ;
Daniel, Maria N. ;
Rosen, Barry P. ;
May, Taymaa ;
Massey, Christine ;
Feigenberg, Tomer .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (05) :922-928